Lin-Yue Lanry Yung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lin-Yue Lanry Yung has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Yan Shan Ang
National University of Singapore
11 shared publications Yan Shan Ang
Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore
10 shared publications- Boon-Huat Bay
Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117594, Singapore
5 shared publications Cheng-Teng Ng
Department of Anatomy, Yong Loo Lin School of Medicine , National University of Singapore , Singapore 117594 , Singapore
5 shared publicationsNianjia Seow
Department of Chemical and Biomolecular Engineering, Faculty of Engineering, National University of Singapore , Singapore 119260, Singapore
4 shared publicationsYahui Gao
Department of Chemical & Biomolecular Engineering
3 shared publications
Latest Publications
- 4 September 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (36) , 26421-26429
A Signal Turn-On DNA Proximity Assay That Correlates with SARS-CoV-2 Blocking Antibody Levels
Surrogate in vitro assays have enabled the scalable testing of neutralizing antibodies to SARS-CoV-2 as a toolbox to manage the post-COVID-19 situation and future outbreaks. However, most surrogate assays use a competitive format to mimic the blocking event between the receptor binding domain (RBD) and the human angiotensin-converting enzyme 2 (ACE2) receptor. This signal “turn-off” format has a narrow dynamic range and is semiquantitative at best. In this proof-of-concept work, we introduce a signal “turn-on” dual antigen assay based on the proximity activation of a pair of RBD-oligonucleotide initiator probes upon bridging by the target antibody. Three well-characterized SARS-CoV-2 variants, i.e., 2019 (wild-type), Delta (B.1.617.2), and Omicron (B.1.1.529), were tested against three commercial antibodies with known RBD-binding and ACE2-blocking profiles. The DNA proximity assay (DPA) results correlated with the ability of the antibodies to block ACE2 instead of their binding to the RBD. Moreover, the single-step, wash-free property of DPA enabled quantification using the kinetic rate of fluorescence signal generation which was more robust than conventional end-point measurements. The DPA achieved good analytical performance with ng/mL detection limit and high assay precision (<5% interassay coefficient of variation), as well as good spike-and-recovery and dilution linearity in serum matrix. The test outcome from three sets of validated vaccine time-series samples were concordant with reference values, demonstrating the potential clinical utility of the DPA platform.
- 4 September 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (36) , 26421-26429
A Signal Turn-On DNA Proximity Assay That Correlates with SARS-CoV-2 Blocking Antibody Levels
Surrogate in vitro assays have enabled the scalable testing of neutralizing antibodies to SARS-CoV-2 as a toolbox to manage the post-COVID-19 situation and future outbreaks. However, most surrogate assays use a competitive format to mimic the blocking event between the receptor binding domain (RBD) and the human angiotensin-converting enzyme 2 (ACE2) receptor. This signal “turn-off” format has a narrow dynamic range and is semiquantitative at best. In this proof-of-concept work, we introduce a signal “turn-on” dual antigen assay based on the proximity activation of a pair of RBD-oligonucleotide initiator probes upon bridging by the target antibody. Three well-characterized SARS-CoV-2 variants, i.e., 2019 (wild-type), Delta (B.1.617.2), and Omicron (B.1.1.529), were tested against three commercial antibodies with known RBD-binding and ACE2-blocking profiles. The DNA proximity assay (DPA) results correlated with the ability of the antibodies to block ACE2 instead of their binding to the RBD. Moreover, the single-step, wash-free property of DPA enabled quantification using the kinetic rate of fluorescence signal generation which was more robust than conventional end-point measurements. The DPA achieved good analytical performance with ng/mL detection limit and high assay precision (<5% interassay coefficient of variation), as well as good spike-and-recovery and dilution linearity in serum matrix. The test outcome from three sets of validated vaccine time-series samples were concordant with reference values, demonstrating the potential clinical utility of the DPA platform.
- 18 July 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (30) , 21115-21127
Sequence Engineering of Guide DNA for Precise RNA Targeting by Cas12a
Cas12a is highly accommodative toward noncanonical activation pathways to the extent of flipping its identity to be a DNA-guided RNA-targeting effector. A sequence engineering approach was used to systematically identify desirable guide DNA (gDNA) sequence motifs to achieve comparable RNA targeting efficiency as the canonical RNA-guided Cas12a with good selectivity down to single-nucleotide mismatch. Importantly, we introduced a split gDNA design concept with greater energetic differences arising from subtle nucleotide changes to probe the key spacer features for effective Cas12a-gDNA activation. Similar to the canonical RNA-guided activation pathway, Cas12a was found to engage actively in the “seed-like” scaffold-proximal region while the scaffold-distal region was largely hybridization-driven. We further evolved the split gDNA design to enhance the sequence selectivity by up to 21-fold compared to a single gDNA design and achieve single-nucleotide discrimination among representative let-7 family members. This study has established a gDNA sequence design framework to reprogram Cas12a as a precise RNA targeting platform.
- 18 July 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (30) , 21115-21127
Sequence Engineering of Guide DNA for Precise RNA Targeting by Cas12a
Cas12a is highly accommodative toward noncanonical activation pathways to the extent of flipping its identity to be a DNA-guided RNA-targeting effector. A sequence engineering approach was used to systematically identify desirable guide DNA (gDNA) sequence motifs to achieve comparable RNA targeting efficiency as the canonical RNA-guided Cas12a with good selectivity down to single-nucleotide mismatch. Importantly, we introduced a split gDNA design concept with greater energetic differences arising from subtle nucleotide changes to probe the key spacer features for effective Cas12a-gDNA activation. Similar to the canonical RNA-guided activation pathway, Cas12a was found to engage actively in the “seed-like” scaffold-proximal region while the scaffold-distal region was largely hybridization-driven. We further evolved the split gDNA design to enhance the sequence selectivity by up to 21-fold compared to a single gDNA design and achieve single-nucleotide discrimination among representative let-7 family members. This study has established a gDNA sequence design framework to reprogram Cas12a as a precise RNA targeting platform.
- Open Access
- 7 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Discriminating single-molecule binding events from diffraction-limited fluorescence
Single-molecule localization microscopy enables high-resolution imaging of molecular interactions, but discriminating molecular binding types has traditionally relied on complex strategies, such as multiple dyes, time-division techniques, or kinetic analysis, that are asynchronous, invasive, or time-consuming. Here, we uncover previously overlooked spatiotemporal information embedded within diffraction-limited fluorescence, enabling synchronous classification of individual binding event videos using only a single fluorescent dye. Building on this insight, we propose a Temporal-to-Context Convolutional Neural Network (T2C CNN), which integrates long-term spatial convolutions, shallow cross-connected blocks, and a pooling-free structure to enhance contextual representation while preserving fine-grained temporal features. Applied to DNA-PAINT experiments, T2C CNN achieves up to 94.76% classification accuracy and outperforms state-of-the-art video classification models by 15-25 percentage points. Our approach enables rapid and precise binding-type recognition from fluorescence video data, reducing observation time from minutes to seconds and facilitating high-throughput single-molecule imaging without requiring multiple dye channels or extended kinetic measurements.
- 7 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open AccessDiscriminating single-molecule binding events from diffraction-limited fluorescence
Single-molecule localization microscopy enables high-resolution imaging of molecular interactions, but discriminating molecular binding types has traditionally relied on complex strategies, such as multiple dyes, time-division techniques, or kinetic analysis, that are asynchronous, invasive, or time-consuming. Here, we uncover previously overlooked spatiotemporal information embedded within diffraction-limited fluorescence, enabling synchronous classification of individual binding event videos using only a single fluorescent dye. Building on this insight, we propose a Temporal-to-Context Convolutional Neural Network (T2C CNN), which integrates long-term spatial convolutions, shallow cross-connected blocks, and a pooling-free structure to enhance contextual representation while preserving fine-grained temporal features. Applied to DNA-PAINT experiments, T2C CNN achieves up to 94.76% classification accuracy and outperforms state-of-the-art video classification models by 15-25 percentage points. Our approach enables rapid and precise binding-type recognition from fluorescence video data, reducing observation time from minutes to seconds and facilitating high-throughput single-molecule imaging without requiring multiple dye channels or extended kinetic measurements.
DNA‐Programmed Reaction to Evaluate Specific IgE for Allergy Point‐of‐Care Testing
A DNA‐programmed reaction to evaluate non‐nucleic acids inputs with computation speed (≈30 min) and sensitivity (sub‐picomolar) suitable for analyzing physiologically relevant biomarkers in a one‐pot format and point‐of‐care testing setting is reported. Specifically, a DNA programme based on the proximity‐activation exponential amplification reaction (PEAR) is designed to evaluate specific IgE (sIgE) against Der p 2 implicated in dust mite allergy which affects millions worldwide. In this work, we tailored the molecular components of the input‐to‐oligo barcode conversion module as an AND gate to detect inputs with binding specificity to Der p 2 antigen and is of an IgE isotype. In addition, an in situ biotinylation method is developed to generate amplified oligo barcodes amendable for direct visualization on a lateral flow format. As a proof‐of‐concept demonstration of its potential clinical utility, 21 clinical samples are evaluated by the as‐developed sIgE PEAR programme using the dual readout modality of real‐time fluorescence measurement for precise input quantification and simple lateral flow yes/no answer.
DNA‐Programmed Reaction to Evaluate Specific IgE for Allergy Point‐of‐Care Testing
A DNA‐programmed reaction to evaluate non‐nucleic acids inputs with computation speed (≈30 min) and sensitivity (sub‐picomolar) suitable for analyzing physiologically relevant biomarkers in a one‐pot format and point‐of‐care testing setting is reported. Specifically, a DNA programme based on the proximity‐activation exponential amplification reaction (PEAR) is designed to evaluate specific IgE (sIgE) against Der p 2 implicated in dust mite allergy which affects millions worldwide. In this work, we tailored the molecular components of the input‐to‐oligo barcode conversion module as an AND gate to detect inputs with binding specificity to Der p 2 antigen and is of an IgE isotype. In addition, an in situ biotinylation method is developed to generate amplified oligo barcodes amendable for direct visualization on a lateral flow format. As a proof‐of‐concept demonstration of its potential clinical utility, 21 clinical samples are evaluated by the as‐developed sIgE PEAR programme using the dual readout modality of real‐time fluorescence measurement for precise input quantification and simple lateral flow yes/no answer.
- 10 February 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (2) , 977-985
CRISPR-Cas12a-Assisted DNA Circuit for Nonmicroscopic Detection of Cell Surface Receptor Clustering
Protein-protein interactions (PPIs) on the cell surface have been of great interest due to their high clinical relevance and significance; however, the methods for detecting PPIs heavily rely on microscopic instruments. In this work, we designed a Cas12a-assisted DNA circuit for detecting cell surface receptor clustering events without a dependence on microscopy. This nonmicroscopic approach is based on the proximity principle, where localized protein-protein interactions such as receptor clustering are converted into DNA barcodes. These barcodes can then be identified by Cas12a for signal generation in the bulk. The compatibility of the circuit with Cas12a was first experimentally verified. Several leak reactions were identified and minimized. Lastly, we implemented this design in human breast cancer cell line models to distinguish the different levels of human epidermal growth factor receptor 2 (HER2) homodimers and heterodimers with HER1 and HER3 semiquantitatively without the use of a microscope. Overall, our proposed Cas12a-assisted DNA circuit for detecting cell surface receptor clustering shows the potential for fast screening in diagnostic applications and drug discovery, demonstrating the promising use of enzymatic DNA circuits in biological applications.
- 10 February 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (2) , 977-985
CRISPR-Cas12a-Assisted DNA Circuit for Nonmicroscopic Detection of Cell Surface Receptor Clustering
Protein-protein interactions (PPIs) on the cell surface have been of great interest due to their high clinical relevance and significance; however, the methods for detecting PPIs heavily rely on microscopic instruments. In this work, we designed a Cas12a-assisted DNA circuit for detecting cell surface receptor clustering events without a dependence on microscopy. This nonmicroscopic approach is based on the proximity principle, where localized protein-protein interactions such as receptor clustering are converted into DNA barcodes. These barcodes can then be identified by Cas12a for signal generation in the bulk. The compatibility of the circuit with Cas12a was first experimentally verified. Several leak reactions were identified and minimized. Lastly, we implemented this design in human breast cancer cell line models to distinguish the different levels of human epidermal growth factor receptor 2 (HER2) homodimers and heterodimers with HER1 and HER3 semiquantitatively without the use of a microscope. Overall, our proposed Cas12a-assisted DNA circuit for detecting cell surface receptor clustering shows the potential for fast screening in diagnostic applications and drug discovery, demonstrating the promising use of enzymatic DNA circuits in biological applications.
- Open Access
- 20 January 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (4) , e202400821
Modulation of CRISPR‐Cas9 Cleavage with an Oligo‐Ribonucleoprotein Design
Clustered regularly interspaced short palindromic repeats (CRISPR) associated protein Cas9 system has been widely used for genome editing. However, the editing or cleavage specificity of CRISPR Cas9 remains a major concern due to the off‐target effects. The existing approaches to control or modulate CRISPR Cas9 cleavage include engineering Cas9 protein and development of anti‐CRISPR proteins. There are also attempts on direct modification of sgRNA, for example, structural modification via truncation or hairpin design, or chemical modification on sgRNA such as partially replacing RNA with DNA. The above‐mentioned strategies rely on extensive protein engineering and direct chemical or structural modification of sgRNA. In this study, we proposed an indirect method to modulate CRISPR Cas9 cleavage without modification on Cas9 protein or sgRNA. An oligonucleotide was used to form an RNA‐DNA hybrid structure with the sgRNA spacer, creating steric hindrance during the Cas9 mediated DNA cleavage process. We first introduced a simple and robust method to assemble the oligo‐ribonucleoprotein (oligo‐RNP). Next, the cleavage efficiency of the assembled oligo‐RNP was examined using different oligo lengths in vitro. Lastly, we showed that the oligo‐RNP directly delivered into cells could also modulate Cas9 activity inside cells using three model gene targets with reduced off‐target effects.
- 20 January 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (4) , e202400821
Open AccessModulation of CRISPR‐Cas9 Cleavage with an Oligo‐Ribonucleoprotein Design
Clustered regularly interspaced short palindromic repeats (CRISPR) associated protein Cas9 system has been widely used for genome editing. However, the editing or cleavage specificity of CRISPR Cas9 remains a major concern due to the off‐target effects. The existing approaches to control or modulate CRISPR Cas9 cleavage include engineering Cas9 protein and development of anti‐CRISPR proteins. There are also attempts on direct modification of sgRNA, for example, structural modification via truncation or hairpin design, or chemical modification on sgRNA such as partially replacing RNA with DNA. The above‐mentioned strategies rely on extensive protein engineering and direct chemical or structural modification of sgRNA. In this study, we proposed an indirect method to modulate CRISPR Cas9 cleavage without modification on Cas9 protein or sgRNA. An oligonucleotide was used to form an RNA‐DNA hybrid structure with the sgRNA spacer, creating steric hindrance during the Cas9 mediated DNA cleavage process. We first introduced a simple and robust method to assemble the oligo‐ribonucleoprotein (oligo‐RNP). Next, the cleavage efficiency of the assembled oligo‐RNP was examined using different oligo lengths in vitro. Lastly, we showed that the oligo‐RNP directly delivered into cells could also modulate Cas9 activity inside cells using three model gene targets with reduced off‐target effects.
- Open Access
Robust Sequence Design Space for the Isothermal Exponential Amplification of Short Oligonucleotides
Advances in isothermal amplification techniques have accelerated development in biosensing applications and the design of complex molecular devices. The exponential amplification reaction technique, or EXPAR, is uniquely positioned to process molecular information from short oligonucleotide strands (≈10 nucleotides length) typically encountered in molecular computing or microRNA detection. Despite its conceptual simplicity (requiring only a template strand and two enzymes), the issue of nonspecific background amplification has hindered broader adoption. In this work, a new system configuration is established at 37 °C to achieve significantly improved performance. Critical sequence motifs responsible for the excellent signal‐to‐background profile are identified and generalized as a universal adapter design framework. Orthogonal template sequences generated from the framework are implemented for a triplex reaction and successfully evaluated mixtures of multiple‐target inputs in a single‐step, one‐pot format without the need for exogenous agents.
Open AccessRobust Sequence Design Space for the Isothermal Exponential Amplification of Short Oligonucleotides
Advances in isothermal amplification techniques have accelerated development in biosensing applications and the design of complex molecular devices. The exponential amplification reaction technique, or EXPAR, is uniquely positioned to process molecular information from short oligonucleotide strands (≈10 nucleotides length) typically encountered in molecular computing or microRNA detection. Despite its conceptual simplicity (requiring only a template strand and two enzymes), the issue of nonspecific background amplification has hindered broader adoption. In this work, a new system configuration is established at 37 °C to achieve significantly improved performance. Critical sequence motifs responsible for the excellent signal‐to‐background profile are identified and generalized as a universal adapter design framework. Orthogonal template sequences generated from the framework are implemented for a triplex reaction and successfully evaluated mixtures of multiple‐target inputs in a single‐step, one‐pot format without the need for exogenous agents.
- 30 July 2024
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 9 (8) , 3928-3937
One-Pot Detection of Proteins Using a Two-Way Extension-Based Assay with Cas12a
Protein biomarkers are an important class of biomarkers in disease diagnosis and are traditionally detected by enzyme-linked immunosorbent assay and mass spectrometry, which involve multiple steps and a complex workflow. In recent years, many CRISPR-Cas12a-based methods for protein detection have been developed; however, most of them have not overcome the workflow complications observed in traditional assays, limiting their applicability in point-of-care testing. In this work, we designed a single-step, one-pot, and proximity-based isothermal immunoassay integrating CRISPR Cas12a for homogeneous protein target detection with a simplified workflow and high sensitivity. Probes consisting of different binders (small molecule, aptamer, and antibody) conjugated with oligonucleotides undergo two-way extension upon binding to the protein targets, leading to downstream DNA amplification by a pair of nicking enzymes and polymerases to generate target sequences for Cas12a signal generation. We used the streptavidin-biotin model to demonstrate the design of our assay and proved that all three elements of protein detection (target protein binding, DNA amplification, and Cas12a signal generation) could coexist in one pot and proceed isothermally in a single buffer system at a low reaction volume of 10 μL. The plug-and-play applicability of our assay has been successfully demonstrated using four different protein targets, streptavidin, PDGF-BB, antidigoxigenin antibody, and IFNγ, with the limit of detection ranging from fM to pM.
- 30 July 2024
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 9 (8) , 3928-3937
One-Pot Detection of Proteins Using a Two-Way Extension-Based Assay with Cas12a
Protein biomarkers are an important class of biomarkers in disease diagnosis and are traditionally detected by enzyme-linked immunosorbent assay and mass spectrometry, which involve multiple steps and a complex workflow. In recent years, many CRISPR-Cas12a-based methods for protein detection have been developed; however, most of them have not overcome the workflow complications observed in traditional assays, limiting their applicability in point-of-care testing. In this work, we designed a single-step, one-pot, and proximity-based isothermal immunoassay integrating CRISPR Cas12a for homogeneous protein target detection with a simplified workflow and high sensitivity. Probes consisting of different binders (small molecule, aptamer, and antibody) conjugated with oligonucleotides undergo two-way extension upon binding to the protein targets, leading to downstream DNA amplification by a pair of nicking enzymes and polymerases to generate target sequences for Cas12a signal generation. We used the streptavidin-biotin model to demonstrate the design of our assay and proved that all three elements of protein detection (target protein binding, DNA amplification, and Cas12a signal generation) could coexist in one pot and proceed isothermally in a single buffer system at a low reaction volume of 10 μL. The plug-and-play applicability of our assay has been successfully demonstrated using four different protein targets, streptavidin, PDGF-BB, antidigoxigenin antibody, and IFNγ, with the limit of detection ranging from fM to pM.
- 4 April 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (15) , 10454-10463
Protein-to-DNA Converter with High Signal Gain
DNA isothermal amplification techniques have been applied extensively for evaluating nucleic acid inputs but cannot be implemented directly on other types of biomolecules. In this work, we designed a proximity activation mechanism that converts protein input into DNA barcodes for the DNA exponential amplification reaction, which we termed PEAR. Several design parameters were identified and experimentally verified, which included the choice of enzymes, sequences of proximity probes and template strand via the NUPACK design tool, and the implementation of a hairpin lock on the proximity probe structure. Our PEAR system was surprisingly more robust against nonspecific DNA amplification, which is a major challenge faced in existing formats of the DNA-based exponential amplification reaction. The as-designed PEAR exhibited good target responsiveness for three protein models with a dynamic range of 4–5 orders of magnitude down to femtomolar input concentration. Overall, our proposed protein-to-DNA converter module led to the development of a stable and robust configuration of the DNA exponential amplification reaction to achieve high signal gain. We foresee this enabling the use of protein inputs for more complex molecular evaluation as well as ultrasensitive protein detection.
- 4 April 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (15) , 10454-10463
Protein-to-DNA Converter with High Signal Gain
DNA isothermal amplification techniques have been applied extensively for evaluating nucleic acid inputs but cannot be implemented directly on other types of biomolecules. In this work, we designed a proximity activation mechanism that converts protein input into DNA barcodes for the DNA exponential amplification reaction, which we termed PEAR. Several design parameters were identified and experimentally verified, which included the choice of enzymes, sequences of proximity probes and template strand via the NUPACK design tool, and the implementation of a hairpin lock on the proximity probe structure. Our PEAR system was surprisingly more robust against nonspecific DNA amplification, which is a major challenge faced in existing formats of the DNA-based exponential amplification reaction. The as-designed PEAR exhibited good target responsiveness for three protein models with a dynamic range of 4–5 orders of magnitude down to femtomolar input concentration. Overall, our proposed protein-to-DNA converter module led to the development of a stable and robust configuration of the DNA exponential amplification reaction to achieve high signal gain. We foresee this enabling the use of protein inputs for more complex molecular evaluation as well as ultrasensitive protein detection.
- Open Access
- 12 October 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (88) , 13167-13170
Design strategies for countering the effect of fluorophore-quencher labelling on DNA hairpin thermodynamics
Fluorophore-quencher labelling induced a significant impact on the DNA hairpin opening thermodynamics. Two practical design strategies to counter this effect are reported.
- 12 October 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (88) , 13167-13170
Open AccessDesign strategies for countering the effect of fluorophore-quencher labelling on DNA hairpin thermodynamics
Fluorophore-quencher labelling induced a significant impact on the DNA hairpin opening thermodynamics. Two practical design strategies to counter this effect are reported.